Patents by Inventor Timothy Riehlman

Timothy Riehlman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEGLYCOSYLATION METHODS FOR ELECTROPHORESIS OF GLYCOSYLATED PROTEINS
    Publication number: 20240053353
    Abstract: The disclosure relates to methods of analyzing a post-translationally modified protein of interest using electrophoresis, the methods comprising deglycosylating the protein of interest after labeling.
    Type: Application
    Filed: October 26, 2023
    Publication date: February 15, 2024
    Inventors: Yiming ZHAO, Hunter CHEN, Shao-Chun WANG, Timothy RIEHLMAN, Gabriel CARREAU, Ying WANG
  • Deglycosylation methods for electrophoresis of glycosylated proteins
    Patent number: 11835527
    Abstract: The disclosure relates to methods of analyzing a post-translationally modified protein of interest using electrophoresis, the methods comprising deglycosylating the protein of interest after labeling.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: December 5, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Yiming Zhao, Hunter Chen, Shao-Chun Wang, Timothy Riehlman, Gabriel Carreau, Ying Wang
  • MICROCHIP CAPILLARY ELECTROPHORESIS ASSAYS AND REAGENTS
    Publication number: 20210333235
    Abstract: Microchip Capillary Electrophoresis (MCE) assays and reagents to assess purity and to identify impurities in protein drug product samples are provided. Methods for analyzing analytes in a protein drug sample are provided.
    Type: Application
    Filed: July 6, 2021
    Publication date: October 28, 2021
    Inventors: Timothy Riehlman, Gabriel Carreau, Jeffrey Schneiderheinze, Nicole M. Nall
  • MICROCHIP CAPILLARY ELECTROPHORESIS ASSAYS AND REAGENTS
    Publication number: 20210293749
    Abstract: MCE assays and reagents to assess purity and to identify impurities in protein drug product samples are provided. Methods for analyzing analytes in a protein drug sample are provided.
    Type: Application
    Filed: June 1, 2021
    Publication date: September 23, 2021
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Timothy Riehlman, Gabriel Carreau, Jeffrey Schneiderheinze, Nicole M. Nall
  • DEGLYCOSYLATION METHODS FOR ELECTROPHORESIS OF GLYCOSYLATED PROTEINS
    Publication number: 20210223256
    Abstract: The disclosure relates to methods of analyzing a post-translationally modified protein of interest using electrophoresis, the methods comprising deglycosylating the protein of interest after labeling.
    Type: Application
    Filed: January 20, 2021
    Publication date: July 22, 2021
    Inventors: Yiming ZHAO, Hunter CHEN, Shao-Chun WANG, Timothy RIEHLMAN, Gabriel CARREAU, Ying WANG
  • Microchip capillary electrophoresis assays and reagents
    Patent number: 11054389
    Abstract: MCE assays and reagents to assess purity and to identify impurities in protein drug product samples are provided. Methods for analyzing analytes in a protein drug sample are provided.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: July 6, 2021
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Timothy Riehlman, Gabriel Carreau, Jeffrey Schneiderheinze, Nicole M. Nall
  • MICROCHIP CAPILLARY ELECTROPHORESIS ASSAYS AND REAGENTS
    Publication number: 20190285580
    Abstract: MCE assays and reagents to assess purity and to identify impurities in protein drug product samples are provided. Methods for analyzing analytes in a protein drug sample are provided.
    Type: Application
    Filed: March 15, 2019
    Publication date: September 19, 2019
    Inventors: Timothy Riehlman, Gabriel Carreau, Jeffrey Schneiderheinze, Nicole Nall